Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches

M Sekhoacha, K Riet, P Motloung, L Gumenku… - Molecules, 2022 - mdpi.com
Simple Summary Prostate cancer affects men of all racial and ethnic groups and leads to
higher rates of mortality in those belonging to a lower socioeconomic status due to late …

[HTML][HTML] Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

M Ashrafizadeh, S Mirzaei, MH Gholami… - Carbohydrate …, 2021 - Elsevier
An important motivation for the use of nanomaterials and nanoarchitectures in cancer
therapy emanates from the widespread emergence of drug resistance. Although doxorubicin …

pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment

A Sathiyaseelan, K Saravanakumar… - Carbohydrate …, 2021 - Elsevier
This study developed the pH, and over-expressed nucleolin receptor responsive nano-drug
delivery system (nDDS) composed by bio-synthesized gold nanoparticles (Au NPs) …

CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition

X Liu, Y Lu, J Huang, Y **ng, H Dai, L Zhu, S Li, J Feng… - Cancer Cell, 2022 - cell.com
The leukocyte Fcγ receptor (FcγR)-mediated response is important for the efficacy of
therapeutic antibodies; however, little is known about the role of FcγRs in other cell types …

Injectable in situ forming thermo-responsive graphene based hydrogels for cancer chemo-photothermal therapy and NIR light-enhanced antibacterial applications

R Lima-Sousa, D de Melo-Diogo, CG Alves… - Materials Science and …, 2020 - Elsevier
Functionalized graphene oxide (GO) and reduced GO (rGO) based nanomaterials hold a
great potential for cancer photothermal therapy. However, their systemic administration has …

Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer

M Imran, S Saleem, A Chaudhuri, J Ali… - Journal of Drug Delivery …, 2020 - Elsevier
Amongst the various microtubule-targeting agents, Docetaxel (DTX) has gained immense
attention in cancer chemotherapy due to its good therapeutic index. DTX belongs to the …

[HTML][HTML] Anti prostate cancer therapy: aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles

Y Chen, Y Deng, C Zhu, C **ang - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Prostate cancer (PC) is the most common type of newly diagnosed malignancy in men.
Combined chemotherapy has been shown to be an effective strategy for the treatment of PC …

Progress and prospects of modified starch-based carriers in anticancer drug delivery

B Zhao, L Li, X Lv, J Du, Z Gu, Z Li, L Cheng… - Journal of Controlled …, 2022 - Elsevier
Recently, the role of starch-based carrier systems in anticancer drug delivery has gained
considerable attention. Although there are same anticancer drugs, difference in their …

Starch-based carriers of paclitaxel: A systematic review of carriers, interactions, and mechanisms

B Zhao, Z Gu, Y Zhang, Z Li, L Cheng, C Li… - Carbohydrate Polymers, 2022 - Elsevier
Paclitaxel, a clinical chemotherapy drug commonly used in the past few years, is greatly
limited by its low therapeutic index. Starch and its derivatives have gained wide interest from …

Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone

G Sun, K Sun, J Sun - Drug Delivery, 2021 - Taylor & Francis
Prostate cancer is the second most frequently diagnosed cancer in the men population.
Combination anticancer therapy using doxorubicin (DOX) and another extract of traditional …